These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 4607506)

  • 21. Hazards in the operating theatre. Serum hepatitis.
    Slawson KB
    Ann R Coll Surg Engl; 1973 Jun; 52(6):365-8. PubMed ID: 4720709
    [No Abstract]   [Full Text] [Related]  

  • 22. Posttransfusion hepatitis: European perspective and prophylaxis.
    Papaevangelou GJ
    Bibl Haematol; 1980; (46):15-22. PubMed ID: 6246871
    [No Abstract]   [Full Text] [Related]  

  • 23. [Proceedings: Prophylaxis of post-transfusion hepatitis (author's transl)].
    Deicher H
    Thoraxchir Vask Chir; 1973 Oct; 21(5):363-9. PubMed ID: 4131107
    [No Abstract]   [Full Text] [Related]  

  • 24. [Post-transfusion hepatitis and the diagnosis of infectious hepatitis in donors (a review of the literature and the authors' own data)].
    Gromashevskaia LL; Khersonskaia RIa; Stroganov BV
    Probl Gematol Pereliv Krovi; 1973 Feb; 18(2):40-5. PubMed ID: 4587776
    [No Abstract]   [Full Text] [Related]  

  • 25. A prospective study of posttransfusion hepatitis. The role of Australia Antigen.
    Gocke DJ
    JAMA; 1972 Feb; 219(9):1165-70. PubMed ID: 5066869
    [No Abstract]   [Full Text] [Related]  

  • 26. Australia antigen and post transfusion hepatitis.
    Berthold H; Kleine N; Büttner G; Müller G
    Prog Immunobiol Stand; 1971; 5():63-6. PubMed ID: 4633979
    [No Abstract]   [Full Text] [Related]  

  • 27. [Post-transfusion hepatitis. Effects of long-term screening for HBsAg carriers among blood donors].
    Pintera J
    Cas Lek Cesk; 1982 Sep; 121(37):1148-52. PubMed ID: 7139671
    [No Abstract]   [Full Text] [Related]  

  • 28. [Australia antigen and transfusion hepatitis. A prospective study on the frequency and prevention of transfusion hepatitis].
    Berthold H; Kleine N; Müller G
    Zentralbl Bakteriol Orig A; 1972 May; 220(1):230-4. PubMed ID: 4145571
    [No Abstract]   [Full Text] [Related]  

  • 29. AABB reacts to rise in hepatitis rates.
    Hospitals; 1971 Nov; 45(22):67-70. PubMed ID: 5128764
    [No Abstract]   [Full Text] [Related]  

  • 30. Australia antigen and serum hepatitis. A prospective study of the frequency of serum hepatitis after transfusion of Au-SH-antigen positive blood units.
    Berthold H; Kleine N; Müller G
    Am J Dis Child; 1972 Apr; 123(4):386-7. PubMed ID: 4623824
    [No Abstract]   [Full Text] [Related]  

  • 31. Prevention of transmission of hepatitis B, hepatitis C and human immunodeficiency virus infections through blood transfusion by anti-HBc testing.
    Busch MP
    Vox Sang; 1998; 74 Suppl 2():147-54. PubMed ID: 9704438
    [No Abstract]   [Full Text] [Related]  

  • 32. Epidemiology of serum hepatitis.
    Ringertz O
    Clin Gastroenterol; 1974 May; 3(2):305-16. PubMed ID: 4607972
    [No Abstract]   [Full Text] [Related]  

  • 33. Posttransfusion hepatitis: epidemiology, experimental studies and US perspective.
    Barker LF
    Bibl Haematol; 1980; (46):3-14. PubMed ID: 6246872
    [No Abstract]   [Full Text] [Related]  

  • 34. [The epidemiologic role of donors who are long-term carriers of the Australian antigen].
    Golosova TV; Kasavina MA; Margolina AN; Kantorovich RA
    Zh Mikrobiol Epidemiol Immunobiol; 1974 Jan; (1):102-5. PubMed ID: 4454805
    [No Abstract]   [Full Text] [Related]  

  • 35. Posttransfusion hepatitis after exclusion of commercial and hepatitis-B antigen-positive donors.
    Alter HJ; Holland PV; Purcell RH; Lander JJ; Feinstone SM; Morrow AG; Schmidt PJ
    Ann Intern Med; 1972 Nov; 77(5):691-9. PubMed ID: 4628213
    [No Abstract]   [Full Text] [Related]  

  • 36. Some epidemiologic studies of transfusion-associated hepatitis.
    Goldfield M
    Infusionstherapie (1973); 1974 Dec; 1(8):645-9. PubMed ID: 4219402
    [No Abstract]   [Full Text] [Related]  

  • 37. [Hepatitis following blood transfusions].
    Busch H; Roos D; Creutzfeldt W
    Dtsch Med Wochenschr; 1971 Oct; 96(43):1694-6. PubMed ID: 5099201
    [No Abstract]   [Full Text] [Related]  

  • 38. Viral hepatitis in dialysis units.
    Goldsmith HJ
    Nephron; 1974; 12(5):355-67. PubMed ID: 4824046
    [No Abstract]   [Full Text] [Related]  

  • 39. Risk of transfusing blood containing antibody to hepatitis-B surface antigen.
    Aach RD; Alter HJ; Hollinger FB; Holland PV; Lander JJ; Melnick JL; Weiler JM
    Lancet; 1974 Jul; 2(7874):190-3. PubMed ID: 4135609
    [No Abstract]   [Full Text] [Related]  

  • 40. Hemophilia, hepatitis and HAA.
    Lewis JH
    Vox Sang; 1970; 19(3):406-9. PubMed ID: 5502767
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.